arrow_back Back to App

Research on Menstrual and Intimate Care Product Safety

This new act aims to research whether popular menstrual and intimate care products contain harmful substances like dioxins or phthalates. The goal is to understand how these components affect health, including the risk of diseases and fertility. This will provide citizens with reliable information on the safety of products they use.
Key points
The act mandates research into the presence of dioxins, phthalates, and other substances in tampons, pads, menstrual cups, and intimate care products (e.g., douches, wipes).
The research will assess health risks, including impacts on gynecological diseases, cancers, fertility, the immune system, and the health of children whose mothers used these products.
The act highlights that current regulations on the safety of these products are limited, with manufacturers often responsible for ensuring their own product safety.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_8724
Sponsor: Rep. Maloney, Carolyn B. [D-NY-12]
Process start date: 2022-08-16
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8724.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-08-16.

What are the main provisions?

Key points include:

  • The act mandates research into the presence of dioxins, phthalates, and other substances in tampons, pads, menstrual cups, and intimate care products (e.g., douches, wipes).
  • The research will assess health risks, including impacts on gynecological diseases, cancers, fertility, the immune system, and the health of children whose mothers used these products.
  • The act highlights that current regulations on the safety of these products are limited, with manufacturers often responsible for ensuring their own product safety.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Maloney, Carolyn B. [D-NY-12].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health